MDClone Launches Generative AI Copilot for Healthcare Data

MDClone was founded by serial entrepreneur Ziv Ofek, who previously founded healthcare IT company dbMotion and sold it to Allscripts for $235 million in 2013. The Israel-based company, founded in 2016, has since raised $104 million from investors including Lightspeed Venture Partners and Orbimed. The new ADAMS Copilot is an AI assistant built on top of MDClone's core ADAMS platform. This platform tackles a major healthcare hurdle by creating "synthetic data"—anonymized, replicable datasets that researchers can analyze without compromising patient privacy. The system is designed for self-service by clinicians and researchers, not programmers. The Copilot itself functions as a natural language interface, translating user questions into complex analytical queries. It operates securely behind a healthcare organization's own firewall, ensuring that large language models can be leveraged without sensitive patient data ever leaving the controlled environment. MDClone has established a significant footprint with major health systems. Its initial partnerships included most of Israel's healthcare market, later expanding to the U.S. with clients like Washington University School of Medicine and Intermountain Healthcare, as well as health systems in Canada. While MDClone is headquartered in Israel, New York City is a major hub for health tech startups applying AI to similar challenges. Companies like Tempus AI and Garner Health are actively building out teams in the city, often seeking engineers with experience in machine learning and AI platforms. The company's trajectory serves as a blueprint for vertical SaaS success. By focusing on a specific, high-stakes industry problem—secure access to healthcare data—MDClone has attracted significant venture capital and a global client base. This approach of building a specialized solution for a complex industry workflow is a common pattern among successful bootstrapped and venture-backed SaaS companies.